Pacific Biosciences of California PACB Inventory write-downs
Inventory write-downs at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:InventoryWriteDown.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's inventory write-downs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's inventory write-downs?
- Pacific Biosciences of California (PACB) reported inventory write-downs of $54K in Q1 2026.
- How has Pacific Biosciences of California's inventory write-downs changed year-over-year?
- Pacific Biosciences of California's inventory write-downs decreased by 99.3% year-over-year, from $7.66M to $54K.
- What is the long-term trend for Pacific Biosciences of California's inventory write-downs?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's inventory write-downs has grown at a 94.8% compound annual growth rate (CAGR), from $678K to $9.77M.
- What does inventory write-downs mean?
- Reflects the non-cash expense recognized when inventory is deemed obsolete, damaged, or valued higher than its net realizable value. High or frequent write-downs may indicate issues with product demand, inventory management, or technological obsolescence.